Jacob Gano

Head Of Antibody Engineering at Protillion Biosciences

Jacob Gano has extensive work experience in the field of biosciences, specifically in antibody engineering and protein engineering. Jacob has held various roles in different companies, starting with their current position as Lead Scientist in Antibody Engineering at Protillion Biosciences. Prior to this, they worked as a Principal Scientist in Antibody Engineering at Neurocrine Biosciences and as a Principal Scientist and Group Leader at Pfizer.

Gano's earlier experience includes working as a Senior Scientist in Antibody Engineering at Inhibrx, Inc., where they were responsible for leading projects from the discovery stage to optimization and library design. Jacob also worked as a Scientist II in Protein Engineering at Amunix, focusing on protein engineering and single-chain antibody development.

Gano's career began with a position as a Research Scientist in Protein Engineering at Stanford University, where they were involved in engineering protein binders and performing in vivo molecular imaging. Jacob also worked as a Scientist II at LS9, Inc., focusing on synthetic biology and enzyme engineering, and as a Scientist at Precision Genome Engineering, where they were involved in engineering homing endonucleases for use in gene therapy.

Earlier in their career, Gano worked as a Scientist at Icogenex Corp, where they assisted in designing assays and screens for neurodegenerative diseases, and as a Graduate Research Scientist at Fred Hutchinson Cancer Research Center, where they conducted proteomics research and studied protein-protein interactions. Overall, Gano's work experience spans a wide range of roles and responsibilities in the field of biosciences.

Jacob Gano received a PhD in Molecular and Cellular Biology from the University of Washington, where they studied from 2001 to 2007. Additionally, they obtained a certification in Technology Entrepreneurship from the University of Washington Foster School of Business Executive Education.

Links

Previous companies

Stanford University logo
Inhibrx logo
Pfizer logo

Timeline

  • Head Of Antibody Engineering

    April 1, 2024 - present

  • Lead Scientist, Antibody Engineering

    October, 2023